Efficacy News and Research

RSS
LigoCyte presents Phase I/II study results of NoV vaccine for gastroenteritis at IDSA Meeting

LigoCyte presents Phase I/II study results of NoV vaccine for gastroenteritis at IDSA Meeting

Vertex initiates OPTIMIZE Phase 3b study in patients infected with genotype 1 HCV

Vertex initiates OPTIMIZE Phase 3b study in patients infected with genotype 1 HCV

S.A.N.E. Vax requests temporary suspension of Gardasil sales as cervical cancer preventive

S.A.N.E. Vax requests temporary suspension of Gardasil sales as cervical cancer preventive

Repros commences randomization in Androxal Phase II study in T2DM men with low testosterone

Repros commences randomization in Androxal Phase II study in T2DM men with low testosterone

First implantation of Neo-Urinary Conduit in bladder cancer patient performed at University of Chicago

First implantation of Neo-Urinary Conduit in bladder cancer patient performed at University of Chicago

GSN initiates trial of microarray PGD on pregnancy and implantation rates in IVF

GSN initiates trial of microarray PGD on pregnancy and implantation rates in IVF

New Canadian Cardiovascular Society guidelines support clinicians in practicing evidence-based medicine

New Canadian Cardiovascular Society guidelines support clinicians in practicing evidence-based medicine

NovaBay delivers two poster presentations on Aganocide compounds at IDSA Annual Meeting

NovaBay delivers two poster presentations on Aganocide compounds at IDSA Annual Meeting

Essentialis, FDA enter agreement on SPA for DCCR Phase 3 efficacy study in patients with high triglycerides

Essentialis, FDA enter agreement on SPA for DCCR Phase 3 efficacy study in patients with high triglycerides

FDA warns about risk of Hyland's Teething Tablets to children

FDA warns about risk of Hyland's Teething Tablets to children

FlexBone shows potential replacement for current bone transplantations

FlexBone shows potential replacement for current bone transplantations

New gene therapy product reduces plasma cholesterol levels

New gene therapy product reduces plasma cholesterol levels

Intercell's IC43 Phase II trial against Pseudomonas aeruginosa infections meets primary endpoint

Intercell's IC43 Phase II trial against Pseudomonas aeruginosa infections meets primary endpoint

Novartis informs Emisphere on First Interpretable Results of two-year Phase III Study 2301 in osteoarthritis

Novartis informs Emisphere on First Interpretable Results of two-year Phase III Study 2301 in osteoarthritis

Revance presents results of RT001 two Phase 2b clinical trials for lateral canthal lines at Chicago annual meeting

Revance presents results of RT001 two Phase 2b clinical trials for lateral canthal lines at Chicago annual meeting

Arena's NDA receives Complete Response Letter for lorcaserin

Arena's NDA receives Complete Response Letter for lorcaserin

New multi-centre trial to treat cold and flu in children

New multi-centre trial to treat cold and flu in children

Medivir reports consolidated net sales of SEK 54.7M

Medivir reports consolidated net sales of SEK 54.7M

EES implantation reduces restenosis, repeat revascularization in patients with calcified culprit lesions

EES implantation reduces restenosis, repeat revascularization in patients with calcified culprit lesions

Inspire presents data on denufosol therapy for cystic fibrosis at NACFC conference

Inspire presents data on denufosol therapy for cystic fibrosis at NACFC conference

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.